Prince Joshua S. has filed 8 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 56248 shares of Vistagen Therapeutics, Inc. ($VTGN) on April 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 7, 2026 | Vistagen Therapeutics, Inc. | $VTGN | Prince Joshua S. | Chief Operating Officer | A | Non-Qualified Stock Option (right to buy) | 56248 | $0.00 | 56,248.0000 | 42,234,405 | 9999.99% | 0.13% |
| April 7, 2026 | Vistagen Therapeutics, Inc. | $VTGN | Prince Joshua S. | Chief Operating Officer | A | Incentive Stock Option (right to buy) | 18752 | $0.00 | 18,752.0000 | 42,234,405 | 9999.99% | 0.04% |
| Dec. 31, 2025 | Vistagen Therapeutics, Inc. | $VTGN | Prince Joshua S. | Chief Operating Officer | A | Common Stock | 4386 | $0.56 | 15,249.0000 | 39,495,451 | 40.38% | 0.01% |
| June 30, 2025 | Vistagen Therapeutics, Inc. | $VTGN | Prince Joshua S. | Chief Operating Officer | A | Common Stock | 4882 | $1.70 | 10,863.0000 | 29,157,733 | 81.63% | 0.02% |
| June 23, 2025 | Vistagen Therapeutics, Inc. | $VTGN | Prince Joshua S. | Chief Operating Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 29,157,733 | 9999.99% | 0.34% |
| Dec. 31, 2024 | Vistagen Therapeutics, Inc. | $VTGN | Prince Joshua S. | Chief Operating Officer | A | Common Stock | 3310 | $2.51 | 5,981.0000 | 30,632,347 | 123.92% | 0.01% |
| June 28, 2024 | Vistagen Therapeutics, Inc. | $VTGN | Prince Joshua S. | Chief Operating Officer | A | Common Stock | 2671 | $2.96 | 2,671.0000 | 19,354,500 | 9999.99% | 0.01% |
| June 24, 2024 | Vistagen Therapeutics, Inc. | $VTGN | Prince Joshua S. | Chief Operating Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 19,354,500 | 9999.99% | 0.78% |